Loading
Latest filing published 27 Nov 2019 for EastWest Bioscience Inc., €6,662.
No signal scores available.
Nathan Lidder is a declared insider of EastWest Bioscience Inc., with filings sourced from SEDI. We count 3 filings; the first trade dates from 27 September 2018 and the latest from 3 April 2019.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 27 November 2019 came the latest disclosure, a transaction for €6,662 in EastWest Bioscience Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations